Healthcare & Life Sciences Industry Updates

Google News – Clinical Trials External News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Eli Lilly’s Ebglyss wins Canadian drug approval for eczema - eciks.org

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo - Macau Business

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (IONS) Phase 3 eplontersen trial in ATTR-CM fails primary goal - Stock Titan

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Satellos’ oral DMD drug improves arm movement after six months in Phase II - Clinical Trials Arena

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Why Patient Stratification Matters in Clinical Trials(1) - Dermatology Times

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Keenova seeks Xiaflex expansion on late-stage rare disease win - Clinical Trials Arena

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

July 9, 2026: Updates From the EquiP PC Trial: An Interview With Kari Stephens - Rethinking Clinical Trials

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Clinical Trials and Smart Packaging: Closing the Knowledge Gap - Healthcare Packaging

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Jefferies cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

BofA cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Oppenheimer cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals: An Unexpected Rival Trial Failure Improves The Core TTR Franchise Outlook - Seeking Alpha

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire

Eli Lilly’s Ebglyss wins Canadian drug approval for eczema - eciks.org

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo - Macau Business

Ionis Pharmaceuticals (IONS) Phase 3 eplontersen trial in ATTR-CM fails primary goal - Stock Titan

Satellos’ oral DMD drug improves arm movement after six months in Phase II - Clinical Trials Arena

Why Patient Stratification Matters in Clinical Trials(1) - Dermatology Times

Keenova seeks Xiaflex expansion on late-stage rare disease win - Clinical Trials Arena

July 9, 2026: Updates From the EquiP PC Trial: An Interview With Kari Stephens - Rethinking Clinical Trials

Clinical Trials and Smart Packaging: Closing the Knowledge Gap - Healthcare Packaging

Jefferies cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

BofA cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

Oppenheimer cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

Alnylam Pharmaceuticals: An Unexpected Rival Trial Failure Improves The Core TTR Franchise Outlook - Seeking Alpha

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan